title: Amyloid plaques are still main target for Alzheimer's drugs.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006801:Humans; D058225:Plaque, Amyloid / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C000600266:aducanumab; C550616:solanezumab